RS Research competitorsClear all

RS Research's top competitors include Karyopharm Therapeutics, Merrimack Pharmaceuticals, CytomX Therapeutics and AVEO Pharmaceuticals.
RS Research
RS Research
RS Research is a pharmaceutical company developing nanomedicines based on innovative drug delivery platforms for targeted cancer therapy.
Karyopharm Therapeutics
Karyopharm Therapeutics
Karyopharm Therapeutics is a clinical-stage pharmaceutical company developing drugs for the treatment of cancer and other major diseases.
Merrimack Pharmaceuticals
Merrimack Pharmaceuticals
Merrimack Pharmaceuticals discovers, designs and develops therapies for the treatment of diseases in the areas of autoimmunity and cancer.
CytomX Therapeutics
CytomX Therapeutics
CytomX is an oncology-focused biopharmaceutical company pioneering a novel class of antibody therapeutics based on Probody technology platform.
AVEO Pharmaceuticals
AVEO Pharmaceuticals
AVEO is a biopharmaceutical company focused on the discovery and development of targeted cancer therapeutics.
Founding Date
Founding Date
2015
Founding Date
2008
Founding Date
2000
Founding Date
2008
Founding Date
2001
Type
Type
Private
Type
Subsidiary
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Epalinges, CH HQ
Locations
Newton, US HQ
München, DE
Tel Aviv Yafo, IL
Locations
Cambridge, US HQ
Locations
South San Francisco, US HQ
Locations
Cambridge, US HQ
Boston, US
Employees
Employees
14
Employees
4224% increase
Employees
2763% decrease
Employees
15815% increase
Employees
1912% increase
Valuation ($)
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
45.1 m
Valuation ($)
349.9 m
Valuation ($)
118.7 m
Twitter followers
Twitter followers
773
Twitter followers
N/A
Twitter followers
1.1 k
Twitter followers
822
Twitter followers
884
Alexa Website Rank
Alexa Website Rank
648045
Alexa Website Rank
312258
Alexa Website Rank
388656
Alexa Website Rank
346479
Alexa Website Rank
383339
Employee Rating
Employee Rating
N/A
Employee Rating
3.6
Employee Rating
3
Employee Rating
3.4
Employee Rating
3.7

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$40.9m (FY, 2019)
Revenue (est.)
N/A
Revenue (est.)
$57.5m (FY, 2019)
Revenue (est.)
$28.8m (FY, 2019)
Net income
Net income
N/A
Net income
($199.6m) (FY, 2019)
Net income
($17.3m) (FY, 2019)
Net income
($102.2m) (FY, 2019)
Net income
$9.4m (FY, 2019)

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
$ 248.7m
Total funding raised
$ 79.4m
Total funding raised
$ 132.4m
Total funding raised
$ 224m
For sources of this data, please see the company profile

View company profiles

Karyopharm Therapeutics
HQ
Newton, US

Karyopharm Therapeutics is a clinical-stage pharmaceutical company developing drugs for the treatment of cancer and other major diseases.

View company
Merrimack Pharmaceuticals
HQ
Cambridge, US
Employees
27

Merrimack Pharmaceuticals discovers, designs and develops therapies for the treatment of diseases in the areas of autoimmunity and cancer.

View company
CytomX Therapeutics
HQ
South San Francisco, US
Employees
158↑ 15% increase

CytomX is an oncology-focused biopharmaceutical company pioneering a novel class of antibody therapeutics based on Probody technology platform.

View company
AVEO Pharmaceuticals
HQ
Cambridge, US
Employees
19↑ 12% increase

AVEO is a biopharmaceutical company focused on the discovery and development of targeted cancer therapeutics.

View company